FOSTER®: Clinical Trials

3 trials of FOSTER®, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting. 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 33Completed 2, Recruiting 1

Follow FOSTER®: new trials by email Literature Review of FOSTER® trials Research Report on FOSTER®

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Beclometasone Dipropionate and Formoterol Inhalation Aerosol for Asthma
Beclometasone Dipropionate and Formoterol Inhalation Aerosol, FOSTER® - Asthma (Diagnosis)
Phase 3RecruitingLunan Better Pharmaceutical Co., LTD.4162026-06-082026-08-17
Foster® pMDI (CHF 1535) Versus Symbicort® Turbohaler in COPD Patient (FORSYYN)
CHF 1535 100/6 µg pMDI plus Symbicort® Turbohaler® Placebo, Symbicort® Turbohaler® plus CHF 1535 pMDI Placebo - Chronic Obstructive Pulmonary Disease
Phase 3CompletedChiesi Farmaceutici S.p.A.7502018-07-302026-05-12
Efficacy of CHF1535 Via NEXT DPI Versus pMDI and BDP DPI100µg on PeakExpiratoryFlow in Asthmatic Patients
CHF 1535 100/6 NEXT DPI® 2 months, CHF 1535 100/6 pMDI 2 months, BDP DPI 2 months - Asthma
Phase 3CompletedChiesi Farmaceutici S.p.A.9322011-03-012017-03-30

Conditions studied

Asthma (2)  ·  Disease (1)  ·  Pulmonary Disease, Chronic Obstructive (1)

Sponsors

Chiesi Farmaceutici S.p.A. (2)  ·  Lunan Better Pharmaceutical Co., LTD. (1)

Countries

China (2)  ·  Poland (1)

Results publications

PMID 25088067, PMID 39529298